73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Genomic deletions explain why some types of melanoma resist targeted therapies

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia

Genomic deletions explain why some types of melanoma resist targeted therapies

byCenter for Genomic RegulationCredit: CC0 Public DomainMelanoma is the deadliest form of skin cancer. With global incidence rates rising, new, more effective treatments are necessary to allevia
Lethal brain tumour shields itself from immune attack

Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest

Lethal brain tumour shields itself from immune attack

by Hayley Jarvis,Brunel UniversityGBM cells can be highly invasive in the brain, or fast growing while being localised. Credit: Dr SK Singh, Gottingen Medical Centre, GermanyOne of the deadliest
Researchers solving treatment resistance in most common breast cancer

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI

Researchers solving treatment resistance in most common breast cancer

by University of Pittsburgh Schools of the Health SciencesMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainAt Magee-Womens Research Institute (MWRI
Researcher helps define subtypes of ovarian cancer

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved

Researcher helps define subtypes of ovarian cancer

by The City University of New YorkCredit: CC0 Public DomainIn a new paper published in the journalClinical Cancer Research, CUNY SPH Associate Professor Levi Waldron and colleagues resolved
Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

by Zhang Nannan,Chinese Academy of SciencesProcess for predicting the NACT efficacy in AGC. Credit: SIBETGastric cancer is a common malignant tumor that originates from the gastric mucosal epith

Predicting efficacy of neoadjuvant chemotherapy for advanced gastric cancer

by Zhang Nannan,Chinese Academy of SciencesProcess for predicting the NACT efficacy in AGC. Credit: SIBETGastric cancer is a common malignant tumor that originates from the gastric mucosal epith
Study shows the benefit of harnessing the body's own immune cells to fight brain cancer

Study shows the benefit of harnessing the body's own immune cells to fight brain cancer

by Salk InstituteCredit: Human Brain ProjectGlioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The tumor sends out cancerous

Study shows the benefit of harnessing the body's own immune cells to fight brain cancer

by Salk InstituteCredit: Human Brain ProjectGlioblastoma, the most common and deadly form of brain cancer, grows rapidly to invade and destroy healthy brain tissue. The tumor sends out cancerous
Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of

Study discovers tumor monocyte content predicts immunochemotherapy outcomes for esophageal cancer

by Ludwig Institute for Cancer ResearchGraphical Abstract. Credit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.006A Ludwig Cancer Research study has discovered that the presence of
Drug yields high response rates for lung cancer patients with harsh mutation

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A

Drug yields high response rates for lung cancer patients with harsh mutation

by University of Texas M. D. Anderson Cancer CenterCredit: University of Texas M. D. Anderson Cancer CenterA targeted therapy resurrected by the Moon Shots Program at The University of Texas MD A
Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

by The Spanish National Cancer Research CentreClinical trial tumor samples: the phosphoprofiles were independent of the study site and/or treatment arm.AClinical trial treatment and s

Researchers discover how to predict the efficacy of one of the most widely used drugs against breast cancer

by The Spanish National Cancer Research CentreClinical trial tumor samples: the phosphoprofiles were independent of the study site and/or treatment arm.AClinical trial treatment and s
Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti

Researchers discover connection between stress-activated signaling and immune cell evasion in melanoma

by H. Lee Moffitt Cancer Center & Research InstituteGraphical abstract. Credit:Cancer Cell(2022). DOI: 10.1016/j.ccell.2022.08.016Anti-cancer immune cells are critical to inhibiti
Hypnotherapy may offer real benefits for cancer patient care

Hypnotherapy may offer real benefits for cancer patient care

byEdith Cowan UniversityCredit: PexelsHypnotherapy could offer a host of benefits to cancer patients; however, arecent studypublished inComplementary Therapies in Clinical Prac

Hypnotherapy may offer real benefits for cancer patient care

byEdith Cowan UniversityCredit: PexelsHypnotherapy could offer a host of benefits to cancer patients; however, arecent studypublished inComplementary Therapies in Clinical Prac